INFORMACIONES PSIQUIÁTRICAS 246

90 Informaciones Psiquiátricas 2022 - n.º 246 Bibliografía 1. Howes, O.D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N.J., Birnbaum, M.L., … & Correll, C.U., 2017. Treatment-resistant schizophrenia: treatment response and re- sistance in psychosis (TRRIP) working group consensus gui- delines on diagnosis and terminology. Am. J. Psychiatry 174, 216–229. 2. Jauhar, S., McKenna, P.J., Radua, J., Fung, E., Salvador, R., Laws, K.R., 2014. Cognitive- behavioural therapy for the symptoms of schizophrenia: systematic review and meta- analysis with exa- mination of potential bias. Br. J. Psychiatry 204, 20–29. 3. Zhou, C., Zhang, H., Qin, Y., Tian, T., Xu, B., Chen, J., Zhou, X., Zeng, L., Fang, L., Qi, X., Lian, B., Wang, H., Hu, Z., Xie, P., 2018. A systematic review and meta-analysis of deep bra- in stimulation in treatment-resistant depression. Prog. Neuro- Psychopharmacol. Biol. Psychiatry 82, 224–232. 4. Corripio, I., Roldan, A., Sarro, S., McKenna, P.J., Alonso-Solis, A., Rabella, M., Diaz, A., Puigdemont, D., Perez-Sola, V., Alva- rez, E., Arevalo, A., Padilla, P.P., Ruiz-Idiago, J. M., Rodriguez, R., Molet, J., Pomarol-Clotet, E., Portella, M.J., 2020. Deep bra- in stimulation in treatment resistant schizophrenia: a pilot ran- domized cross-over clinical trial. EBioMedicine 51, 102568. 5. Abi-Dargham, A., Gil, R., Krystal, J., Baldwin, R.M., Seibyl, J.P., Bowers, M., van Dyck, C. H., Charney, D.S., Innis, R.B., Laruelle, M., 1998. Increased striatal dopamine transmission in schizo- phrenia: confirmation in a second cohort. Am. J. Psychiatry 155, 761–767. 6. Howes, O.D., Bonoldi, I., McCutcheon, R.A., Azis, M., Antonia- des, M., Bossong, M., Modinos, G., Perez, J., Stone, J.M., San- tangelo, B., Veronese, M., Grace, A., Allen, P., McGuire, P.K., 2020. Glutamatergic and dopaminergic function and the rela- tionship to outcome in people at clinical high risk of psycho- FIDMAG informa